Form 4: Avadel Pharmaceuticals PLC: Insider Transactions by Geoffrey Michael Glass

Geoffrey Michael Glass, a co-trustee and sole beneficiary, has reported transactions involving Avadel Pharmaceuticals PLC ordinary shares held in trust.

Summary

• Geoffrey Michael Glass, through two trusts, has engaged in transactions involving Avadel Pharmaceuticals PLC ordinary shares.
• On December 10, 2024, The Geoffrey Glass Trust acquired 10,075 ordinary shares at a price of $9.89 per share.
• On the same day, the Geoffrey M. Glass Revocable Trust U/T/D August 26, 2020 acquired 10,204 ordinary shares at a price of $9.80 per share.
• A total of 11,000 ordinary shares were disposed of.
• The reporting person is the sole beneficiary of The Geoffrey Glass Trust and the sole beneficiary along with immediate family members of the Geoffrey M. Glass Revocable Trust.

Sentiment

Score: 5

Explanation: The document is a routine filing of insider transactions, with no indication of positive or negative sentiment.

Industry Context

This filing reflects routine insider trading activity and is not indicative of any broader industry trends.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies, and these transactions are within the normal range of such activities.
• The share prices at which the transactions occurred are consistent with the market price of Avadel Pharmaceuticals PLC shares at the time of the transactions.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they are routine insider transactions.

Key Dates

Keywords

Avadel Pharmaceuticals, Insider Trading, Share Transactions, Ordinary Shares, Trust, Beneficiary, Geoffrey Glass